These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23969960)

  • 1. Identifying the criteria of a valid stability study.
    Williams LA; Hastings MB
    Int J Pharm Compd; 2009; 13(1):32-6. PubMed ID: 23969960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basics of compounding: potency and stability testing.
    Allen LV
    Int J Pharm Compd; 2013; 17(3):220-4. PubMed ID: 24046938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basics of compounding: basics of compounding with esters.
    Allen LV
    Int J Pharm Compd; 2010; 14(5):416-8. PubMed ID: 23965586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond-use date: establishment and maintenance.
    Osteen R
    Int J Pharm Compd; 2012; 16(6):471-4. PubMed ID: 23259362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of compounding: basics of compounding with aliquots, dilutions, and concentrates.
    Allen LV
    Int J Pharm Compd; 2010; 14(6):508-10. PubMed ID: 23965655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability Versus Potency Testing: The Madness is in the Method.
    Kupiec TC; Skinner R; Lanier L
    Int J Pharm Compd; 2008; 12(1):50-3. PubMed ID: 23969572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine in compounded oral and topical preparations.
    McCluskey SV; Brunn GJ
    Int J Pharm Compd; 2011; 15(2):166-9. PubMed ID: 23696085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability testing requirements for vaccines--draft guidelines of the International Conference on Harmonization.
    Haase M
    Dev Biol Stand; 1996; 87():309-18. PubMed ID: 8854031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics of compounding: basics of compounding with organic salts.
    Allen LV
    Int J Pharm Compd; 2010; 14(4):322-6. PubMed ID: 23965540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of vancomycin in SyrSpend SF.
    Whaley PA; Voudrie MA
    Int J Pharm Compd; 2012; 16(2):167-9. PubMed ID: 23050329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standards of practice, professional judgment, and scientific evidence to establish and extend a beyond-use date.
    Thomson CM; Savji T
    Int J Pharm Compd; 2014; 18(6):456-60. PubMed ID: 25906621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. stab: an R package for drug stability data analysis.
    Lee HY; Wu PC; Lee YJ
    Comput Methods Programs Biomed; 2010 Nov; 100(2):140-8. PubMed ID: 20363045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basics of compounding: basics of compounding with inorganic salts.
    Allen LV
    Int J Pharm Compd; 2011; 15(2):146-55. PubMed ID: 23696084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life - an always reliable approach?
    Pfleiderer M
    Biologicals; 2009 Nov; 37(6):364-8. PubMed ID: 19773184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of rifampin in SyrSpend SF.
    Sorenson B; Whaley P
    Int J Pharm Compd; 2013; 17(2):162-4. PubMed ID: 23696177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjusting dissolution specifications for the variability induced by storage conditions.
    Reynolds JM; Rogers DH
    J Biopharm Stat; 2000 Aug; 10(3):425-31. PubMed ID: 10959921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance levels for stability pooling test: a simulation study.
    Chen WJ; Tsong Y
    J Biopharm Stat; 2003 Aug; 13(3):355-74. PubMed ID: 12921387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the stability of acetaminophen in pluronic lecithin organogel and the determination of an appropriate beyond-use date.
    Peacock GF; Sauvageot J
    Int J Pharm Compd; 2012; 16(5):428-30. PubMed ID: 23072202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study.
    Huyghebaert N; De Beer J; Vervaet C; Remon JP
    J Clin Pharm Ther; 2007 Oct; 32(5):489-96. PubMed ID: 17875116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of compounding and storage conditions on stability of pergolide mesylate.
    Davis JL; Kirk LM; Davidson GS; Papich MG
    J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.